|
AU2018205621A1
|
|
Method of administering nitroxyl donating compounds
|
|
EP3365325A1
|
|
N-hydroxylsulfonamide derivatives as nitroxyl donors
|
|
CN108473439A
|
|
Pyrazolone derivative as nitroxyl donors
|
|
AU2016206320A1
|
|
N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors
|
|
US2015344437A1
|
|
Pyrazolone derivatives as nitroxyl donors
|
|
WO2015109210A1
|
|
N-hydroxymethanesulfonamide nitroxyl donors
|
|
AU2014201605A1
|
|
N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors
|
|
EP2945621A1
|
|
Pharmaceutical compositions comprising nitroxyl donors
|
|
AU2010328234A1
|
|
N-acyloxysulfonamide and N-hydroxy-N-acylsulfonamide derivatives
|
|
WO2011063339A1
|
|
Nitroxyl donors for the treatment of pulmonary hypertension
|
|
EP3067352A2
|
|
Novel nitroso compounds as nitroxyl donors and methods of use thereof
|
|
BRPI0708804A2
|
|
n-hydroxylsulfonamide-derived compounds as nitroxyl donors, pharmaceutical composition and kit
|
